These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1120 related items for PubMed ID: 9825576

  • 61. Treatment of acute lymphoblastic leukemia in Hong Kong children: HKALL 93 study.
    Li CK, Chik KW, Chan GC, Yuen HL, Lee AC, Li CK, Shing MM, Ha SY, Luk CW, Ling SC, Cheung AY, Hong Kong Paediatric Haematology & Oncology Study Group.
    Hematol Oncol; 2003 Mar; 21(1):1-9. PubMed ID: 12605417
    [Abstract] [Full Text] [Related]

  • 62. Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia.
    Clavell LA, Gelber RD, Cohen HJ, Hitchcock-Bryan S, Cassady JR, Tarbell NJ, Blattner SR, Tantravahi R, Leavitt P, Sallan SE.
    N Engl J Med; 1986 Sep 11; 315(11):657-63. PubMed ID: 2943992
    [Abstract] [Full Text] [Related]

  • 63.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 64. Improvement in treatment of childhood acute lymphoblastic leukemia: a 10-year study by the Children's Cancer and Leukemia Study Group.
    Koizumi S, Fujimoto T.
    Int J Hematol; 1994 Feb 11; 59(2):99-112. PubMed ID: 8018909
    [Abstract] [Full Text] [Related]

  • 65.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 66.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 67.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 68. Intensive chemotherapy for childhood acute lymphoblastic leukemia: results of the randomized intercontinental trial ALL IC-BFM 2002.
    Stary J, Zimmermann M, Campbell M, Castillo L, Dibar E, Donska S, Gonzalez A, Izraeli S, Janic D, Jazbec J, Konja J, Kaiserova E, Kowalczyk J, Kovacs G, Li CK, Magyarosy E, Popa A, Stark B, Jabali Y, Trka J, Hrusak O, Riehm H, Masera G, Schrappe M.
    J Clin Oncol; 2014 Jan 20; 32(3):174-84. PubMed ID: 24344215
    [Abstract] [Full Text] [Related]

  • 69. Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM-90 and CoALL-05-92.
    Schlieben S, Borkhardt A, Reinisch I, Ritterbach J, Janssen JW, Ratei R, Schrappe M, Repp R, Zimmermann M, Kabisch H, Janka-Schaub G, Bartram CR, Ludwig WD, Riehm H, Lampert F, Harbott J.
    Leukemia; 1996 Jun 20; 10(6):957-63. PubMed ID: 8667652
    [Abstract] [Full Text] [Related]

  • 70. Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997-2004).
    Veerman AJ, Kamps WA, van den Berg H, van den Berg E, Bökkerink JP, Bruin MC, van den Heuvel-Eibrink MM, Korbijn CM, Korthof ET, van der Pal K, Stijnen T, van Weel Sipman MH, van Weerden JF, van Wering ER, van der Does-van den Berg A, Dutch Childhood Oncology Group.
    Lancet Oncol; 2009 Oct 20; 10(10):957-66. PubMed ID: 19747876
    [Abstract] [Full Text] [Related]

  • 71. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.
    Güneş AM, Oren H, Baytan B, Bengoa SY, Evim MS, Gözmen S, Tüfekçi O, Karapınar TH, Irken G.
    Ann Hematol; 2014 Oct 20; 93(10):1677-84. PubMed ID: 24863691
    [Abstract] [Full Text] [Related]

  • 72. High survival rate in childhood non-Hodgkin lymphoma without CNS involvement: results of BFM 95 study in Kuwait.
    Mottl H, Bajciova V, Nemec J, Al Shemmari S, Al Awadi S.
    Pediatr Hematol Oncol; 2003 Mar 20; 20(2):103-10. PubMed ID: 12554521
    [Abstract] [Full Text] [Related]

  • 73. Therapy of B-cell acute lymphoblastic leukaemia in childhood: the BFM experience.
    Reiter A.
    Baillieres Clin Haematol; 1994 Jun 20; 7(2):321-37. PubMed ID: 7803904
    [Abstract] [Full Text] [Related]

  • 74. [The prospects for children with acute lymphoblastic leukemia of being cured has increased in the Czech Republic in the 21st century to 90% - outcome of the ALL-IC BFM 2002 trial].
    Zdráhalová K, Štěrba J, Domanský J, Blažek B, Ptoszková H, Mihál V, Novák Z, Hak J, Procházková D, Černá Z, Timr P, Jabali Y, Sedláček P, Smíšek P, Zemanová Z, Jarošová M, Houdková A, Mejstříková E, Hrušák O, Zuna J, Janotová I, Trka J, Starý J.
    Cas Lek Cesk; 2015 Jun 20; 154(2):79-89. PubMed ID: 25994910
    [Abstract] [Full Text] [Related]

  • 75. Management of Ontario children with acute lymphoblastic leukemia by the Dana-Farber Cancer Institute protocols.
    Desai SJ, Barr RD, Andrew M, deVeber LL, Pai MK.
    CMAJ; 1989 Oct 01; 141(7):693-7. PubMed ID: 2790605
    [Abstract] [Full Text] [Related]

  • 76. Analysis of growth failure in children treated for acute lymphoblastic leukemia.
    Sato J, Ninomiya T, Tsuda Y, Komazawa M, Nagata K, Iwai A, Nishikawa K, Maeda H, Ohmiya A, Ohta M.
    Int J Hematol; 1992 Dec 01; 56(3):205-12. PubMed ID: 1477332
    [Abstract] [Full Text] [Related]

  • 77.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 78.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 79. A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.
    Larson RA, Dodge RK, Burns CP, Lee EJ, Stone RM, Schulman P, Duggan D, Davey FR, Sobol RE, Frankel SR.
    Blood; 1995 Apr 15; 85(8):2025-37. PubMed ID: 7718875
    [Abstract] [Full Text] [Related]

  • 80.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 56.